Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid Tumors
Clinical trial NCT00121277 · COMPLETED
Trial details
- NCT number
- NCT00121277
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2009-08-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.